Rates of dyspepsia one year after Helicobacter pylori screening and eradication in a Danish population

Gastroenterology

Volumn 125, Issue 2, 2003, Pages 372-379

  Wildner Christensen, Mette ^a   Hansen, Jane Møller ^a   Schaffalitzky de Muckadell, Ove B ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; ANTACID AGENT; ANTIULCER AGENT; CARBON 13; CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CANCER RISK; CLINICAL FEATURE; CONTROLLED STUDY; DENMARK; DRUG HYPERSENSITIVITY; DYSPEPSIA; ENDOSCOPY; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZATION; SCREENING; STOMACH CANCER; TREATMENT OUTCOME; UREA BREATH TEST;

EID: 0043167986     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(03)00897-7     Document Type: Article

References (30)

1. Westbrook JI, McIntosh JH, Talley NJ. The impact of dyspepsia definition on prevalence estimates: considerations for future researchers. Scand J Gastroenterol 2000;35:227-233.
2. van Bommel MJ, Numans ME, de Wit NJ, Stalman WA. Consultations and referrals for dyspepsia in general practice: a one year database survey. Postgrad Med J 2001;77:514-518.
3. Lindell GH, Celebioglu F, Graffner HO. Non-ulcer dyspepsia in the long-term perspective. Eur J Gastroenterol Hepatol 1995;7:829-833.
4. Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ 1993;306:1440-1444.
5. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996;110:1244-1252.
6. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-789.
7. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-353.
8. Moayyedi P, Soo S, Deeks J, Forman D, Mason J, Innes M, Delaney B. Dyspepsia Review Group. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. BMJ 2000;321:659-664.
9. Laine L, Schoenfeld P, Fennerty MB. Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001;134:361-369.
10. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112:1442-1447.
11. Malfertheiner P, Dent J, Zeijlon L, Sipponen P, Veldhuyzen Van Zanten SJ, Burman CF, Lind T, Wrangstadh M, Bayerdorffer E, Lonovics J. Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease: results from a randomized trial programme. Aliment Pharmacol Ther 2002;16:1431-1442.
12. Talley NJ, Jansen JB, Lauritsen K, Bolling-Sternevald E, Havu N, Junghard O, Sjogren G. No increase of reflux symptoms in patients with non-ulcer dyspepsia 12 months after Helicobacter pylori eradication. A randomized double-blind placebo-controlled trial. Gastroenterology 1998;114(suppl):A306.
13. Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Quality of life in patients with upper gastrointestinal symptoms: An improved evaluation of treatment regimens? Scand J Gastroenterol 1993;28:681-687.
14. Svedlund J, Sjodin I, Dotevall G. GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988;33:129-134.
15. Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995;30:1046-1052.
16. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
17. Bjorner JB, Damsgaard MT, Watt T, Bech P, Rasmussen NK, Kristensen TS, Modvig J, Thunedborg K. Dansk manual til SF-36. Et spørgeskema om helbredsstatus. 1997. Lægemiddelindustriforeningen, Denmark.
18. Schrier WH, Schoengold RJ, Baker JT, Norell JL, Jaseph CL, Okin Y, Doe JY, Chandler H. Development of FlexSure HP - an immunochromatographic method to detect antibodies against Helicobacter pylori. Clin Chem 1998;44:293-298.
19. Lassen AT. Helicobacter pylori eradication in management of dyspepsia. Thesis, University of Southern Denmark, 2000.
20. Befolkningen efter område, socioøkonomisk grp., herkomst, alder og køn (RAS11), Tabel: Folketal pr. 1. juli efter område, civilstand, alder og køn (BEF6). Danmarks Statistik. 2002. www. statistikbanken.dk/statbank5a/default.asp?w=1024.
21. Moayyedi P, Feltbower R, Brown J, Mason S, Mason J, Nathan J, Richards ID, Dowell AC, Axon AT. Leeds HELP Study Group. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Lancet 2000;355:1665-1669.
22. Lane JA. Effect of eradication of Helicobacter pylori infection in the community on the incidence of dyspepsia: The Bristol Helicobacter project. Gastoenterology 2002;122(suppl 1):A475.
23. Hansen JM, Bytzer P, Bondesen S, Schaffalitzky de Muckadell OB. Efficacy and outcome of an open access endoscopy service. Dan Med Bull 1991;38:288-290.
24. Lane JA, Harvey RF, Murray LJ, Harvey IM, Donovan JL, Nair P, Egger M. A placebo-controlled randomized trial of eradication of Helicobacter pylori in the general population: study design and response rates of the Bristol Helicobacter Project. Control Clin Trials 2002;23:321-332.
25. Colin-Jones DG. Management of dyspepsia: report of a working party. Lancet 1988;12:576-579.
26. Wildner-Christensen M, Hansen JM, Schaffalitzky de Muckadell OB. Low prevalence of Helicobacter pylori infection in the population in the county of Funen Denmark and its relation to dyspepsia. Gastroenterology 2001;120(suppl 1):A735.
27. Sipponen P, Varis K, Fraki O, Korri UM, Seppala K, Siurala M. Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis: A clinical follow-up study of 454 outpatients. Scand J Gastroenterol 1990;25:966-973.
28. Vincze A, Karadi O, Hunyady B, Pakodi F, Suto G, Mozsik G. One year follow-up of patients after successful Helicobacter pylori eradication therapy. J Physiol Paris 2001;95:457-460.
29. Bytzer P, Aalykke C, Rune S, Weywadt L, Gjorup T, Eriksen J, Bonnevie O, Bekker C, Kromann-Andersen H, Kjaergaard J, Rask-Madsen J, Vilien M, Hansen J, Justesen T, Vyberg M, Teglbjaerg PS. Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease: A randomized trial with 2-year follow-up. The Danish Ulcer Study Group. Scand J Gastroenterol 2000;35:1023-1032.
30. Harvey R, Lane J, Donovan J, Murray L, Harvey I, Nair S, Egger M. Paradoxical dual effect of Helicobacter pylori eradication therapy on the heartburn and gastro-esophageal reflux: the Bristol Helicobacter pylori project. Gastroenterology 2002;122(suppl 1):A782.